Lupus nephritis: Lessons from experimental animal models

Journal of Laboratory and Clinical Medicine

Volumn 137, Issue 4, 2001, Pages 244-260

  Peutz Kootstra, C J ^a,b,c   De Heer, E ^a,b,c   Hoedemaeker, Ph J ^a,b,c   Abrass, C K ^a,b,c   Bruijn, J A ^a,b,c  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0035075682     PISSN: 00222143     EISSN: None     Source Type: Journal    
DOI: 10.1067/mlc.2001.113755     Document Type: Article

References (263)

1. Medical progress: Systemic lupus erythematosus
2. Lupus nephritis
3. Relevance of systemic lupus erythematosus nephritis animal models to human disease
4. Systemic lupus erythematosus: Emerging concepts. Part 1: Renal, neuropsychiatric, cardiovascular, pulmonary, and hematologic disease
5. Lupus nephritis: Pathology, pathogenesis, clinicopathological correlations and prognosis
6. A multicenter study of outcome in systemic lupus erythomatosus. I. Entry variables as predictors of prognosis
7. Lupus nephritis
8. The course and treatment of lupus nephritis
9. Renal involvement in systemic lupus erythematosus
10. Animal models of systemic lupus erythematosus
11. Interaction of mutant lpr gene with background strain influences renal disease
12. Pathogenesis of the glomerulonephritis of NZB/W mice
13. A search for the underlying mechanisms of systemic autoimmune disease in the NZBxSWR model
14. The NZB x SWR model of lupus nephritis. II. Autoantibodies deposited in renal lesions show a distinctive and restricted idiotype diversity
15. The immunology and pathology of NZB mice
16. A Y chromosome-associated factor in strain BXSB producing accelerated autoimmunitiy and lymphoproliferation
17. (SWR x SJL)F1 mice: A new model of lupus-like disease
18. Induction and progression of experimental lupus nephritis: Exploration of a pathogenetic pathway
19. Non-MHC genes determine the development of lupus nephritis in H-2 identical mouse strains
20. Murine graft-versus-host disease: A model for study of mechanisms that generate autoantibodies to ribonucleoproteins
21. Renal immunopathology in murine host-versus-graft disease
22. Induction of a systemic lupus erythematosus-like disease in mice by a common human anti-DNA idiotype
23. Spontaneous murine lupus-like syndromes: Clinical and immunopathological manifestations in several strains
24. IgG3 production in MRL/lpr mice is responsible for development of lupus nephritis
25. Characterization of cross-reactive anti-DNA autoantibodies in murine lupus
26. A systemic lupus erythematosus (SLE)-like disease in mice induced by abnormal T-B cell cooperation. Preferential formation of autoantibodies characteristic of SLE
27. Autoimmunity to histones, ubiquitin, and ubiquitinated histone H2A in NZB x NZW and MRL-lpr/lpr mice. Anti-histone antibodies are concentrated in glomerular eluates of lupus mice
28. Autoimmunization in murine graft-vs-host disease I. Selective production of antibodies to histones and DNA
29. Antibodies to DNA, chromatin core particles and histones in mice with graft-versus-host disease and their involvement in glomerular injury
30. Nucleosome-restricted antibodies are detected before anti-dsDNA and/or antihistone antibodies in serum of MRL-Mp lpr/lpr and +/+ mice, and are present in kidney eluates of lupus mice with proteinuria
31. Anti-nucleosome antibodies complexed to nucleosomal antigens show anti-DNA reactivity and bind to rat glomerular basement membrane in vivo
32. Presence of anti-Sm reactivity in autoimmune mouse strains
33. Fine specificities of anti-nuclear antibodies in murine models models of graft-versus-host disease
34. Autoantibodies to transfer RNA-associated protein in a murine model of chronic graft versus host disease
35. Autoantibody production is associated with polyclonal B cell activation in autoimmune mice which express the lpr or gld genes
36. Binding of cytoskeletal proteins by monoclonal anti-DNA lupus autoantibodies
37. A peripheral and central T cell antigen recognized by a monoclonal thymocytotoxic autoantibody from New Zealand black mice
38. Lupus autoantibodies interact directly with distinct glomerular and vascular cell surface antigens
39. Pathogenesis of experimental lupus nephritis: A role for anti-basement membrane and anti-tubular brush border antibodies in murine chronic graft-versus-host disease
40. Autoantibodies to the collagenous region of C1q occur in three strains of lupus-prone mice
41. Cross-reactivity of monoclonal anti-DNA antibodies with heparan sulfate is mediated via bound DNA/histone complexes
42. Glomerular binding activity in MRL lpr serum consists of antibodies that bind to a DNA/histone/type IV collagen complex
43. A murine nephritogenic monoclonal anti-DNA autoantibody binds directly to mouse laminin, the major non-collagenous protein component of the glomerular basement membrane
44. Molecular analysis of spontaneous nephrotropic anti-laminin antibodies in an autoimmune MRL-lpr/lpr mouse
45. Antigen-specificity of antibodies bound to glomeruli of mice with systemic lupus erythematosus-like syndromes
46. Murine models of systemic lupus erythematosus
47. Murine chronic graft-versus-host disease as a model for lupus nephritis
48. A histologic study of the extracellular matrix during the development of glomerulosclerosis in murine chronic graft-versus-host disease
49. Polyclonal activation and experimental nephropathies
50. Induction of immunoglobulin and antibody synthesis in vitro by lipopolysaccharides
51. The autoantigen-binding B cell repertoires of normal and of chronically graft-versus-host-diseased mice
52. A correlation between IgG class antibody production and glomerulonephritis in the murine chronic graft-versus-host reaction
53. Structural characteristics of the variable regions of immunoglobulin genes encoding a pathogenic autoantibody in murine lupus
54. Somatic diversification and affinity maturation of 1gM and IgG anti-DNA antibodies in murine lupus
55. Polyreactive autoantibodies are nephritogenic in murine lupus nephritis
56. Independently derived IgG anti-DNA autoantibodies from two lupus-prone mouse strains express a VH gene that is not present in most murine strains
57. The VH gene sequences of anti-DNA antibodies in two different strains of lupus-prone mice are highly related
58. H gene sequences
59. Nephritogenic autoantibodies in systemic lupus erythematosus: Immunochemical properties, mechanisms of immune deposition, and genetic origin
60. Emerging concepts regarding B cells and autoantibodies in murine lupus nephritis: B cells have multiple roles; all antibodies are not equal
61. Differences in V kappa gene utilization and VH CDR3 sequence among anti-DNA from C3H-lpr mice and lupus mice with nephritis
62. Lupus: Key pathogenic mechanisms and contributing factors
63. Inquiry into murine and human lupus
64. T lymphocytes, cytokines, and immune regulation in systemic lupus erythematosus
65. Systemic autoimmune disease arises from polyclonal B cell activation
66. Polyclonal B cell activation in lupus-prone mice precedes and predicts the development of autoimmune disease
67. Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis
68. Aberrant transcription caused by the insertion of an early transposable element in an intron of the Fas antigen gene of lpr mice
69. Apoptosis abnormalities of splenic lymphocytes in autoimmune lpr and gld mice
70. Mature CD4+ T lymphocytes from MRL/lpr mice are resistant to receptor-mediated tolerance and apoptosis
71. Polyclonal B cell activation arises from different mechanisms in lupus-prone (NZB x NZW) F1 and MRL/MpJ-lpr/lpr mice
72. Development of autoimmune disease in SCID mice populated with long-term 'in vitro' proliferating (NZBxNZW)F1 pre-B cells
73. Loss of suppressor T cells in adult NZB/NZW mice
74. T-cell interactions in autoimmunity: Insights from a murine model of graft-versus-host disease
75. Kinetics of Th1 and Th2 cytokine production during the early course of acute and chronic murine graft-versus-host disease: Regulatory role of donor CD8+ T cells
76. Generation of B cell memory and affinity maturation: Induction with Th1 and Th2 T cell clones
77. Regulation of IgG1 and IgE production by interleukin 4
78. Interleukin-6: An overview
79. IL-10 selectively regulates murine Ig isotype switching
80. Development of murine lupus in CD4-depleted NZB/NZW mice. Sustained inhibition of residual CD4+ T cells is required to suppress autoimmunity
81. Persistence of allospecific helper T cells is required for maintaining autoantibody formation in lupus-like graft-versus-host disease
82. The contribution of L3T4+ T cells to lymphoproliferation and autoantibody production in MRL-lpr/lpr mice
83. Successful treatment of autoimmunity in NZB/NZW F1 mice with monoclonal antibody to L3T4
84. Murine lupus in the absence of alpha beta T cells
85. Nucleosome: A major immunogen for pathogenic autoantibody-inducing T cells of lupus
86. Attenuation of autoimmune disease and lymphocyte accumulation in MRL/lpr mice by treatment with anti-Vβ8 antibodies
87. Immune tolerance to autoantibody-derived peptides delays development of autoimmunity in murine lupus
88. A peptide derived from an autoantibody can stimulate T cells in the (NZB X NZW)F1 mouse model of systemic lupus erythematosus
89. Natural killer cells inhibit the development of autoantibody production in (C57BL/6 x DBA/2) F1 hybrid mice injected with DBA/2 spleen cells
90. Depletion of natural killer cells in mice by a monoclonal antibody to NK1.1
91. Does depression of NK activity cause lymphadenopathy in lpr mice?
92. Natural killer cells induce activated murine B cells to secrete Ig
93. Preferential dependence of autoantibody production in murine lupus on CD86 costimulatory molecule
94. Interaction between CD40 and its ligand gp39 in the development of murine lupus nephritis
95. Immunological tolerance in germinal centres
96. B cells in systemic autoimmune disease: Recent insights from Fas-deficient mice and men
97. Self antigens and epitope spreading in systemic autoimmunity
98. A model of peptide-induced lupus autoimmune B cell epitope spreading is strain specific and is not H2-restricted in mice
99. The role of cytokines in the immunopathogenesis of lupus
100. The cytokine network in the pathogenesis of systemic lupus erythematosus and possible therapeutic implications
101. Cytokines in the pathogenesis of systemic lupus erythematosus
102. TH1 and TH2 cells: Different patterns of lymphokine secretion lead to different functional properties
103. Cytokine secretion by C3H-lpr and -gld T cells. Hyper-secretion of IFN-gamma and tumour necrosis factor-alpha by stimulated CD4+ T cells
104. Age-associated increase in interleukin 6 in MRL/lpr mice
105. The role of interleukin 12 and nitric oxide in the development of spontaneous autoimmune disease in MRL:MP-lpr:lpr mice
106. Interleukin-6 receptor blockage ameliorates murine lupus nephritis
107. In vivo treatment of (NZB x NZW)F1 lupus-like nephritis with monoclonal antibody to gamma interferon
108. Continuous administration of anti-interleukin 10 antibodies delays onset of autoimmunity in NZB/W F1 mice
109. Experimental therapy of systemic lupus erythematosus: The treatment of NZB/W mice with mouse soluble interferon-gamma receptor inhibits the onset of glomerulonephritis
110. Interleukin 6 promotes murine lupus in NZB/NZW F1 mice
111. Roles of IL-4 and IL-12 in the development of lupus in NZB/W F1 mice
112. Preferential activation of Th2 cells in chronic graft-versus-host reaction
113. Effects of in vivo administration of interferon (IFN)-γ anti-IFN-γ, or anti-interleukin-4 monoclonal antibodies in chronic autoimmune graft-versus-host disease
114. Mechanisms of glomerular injury in immune-complex disease
115. Formation of immune deposits and disease
116. Pathogenesis of anti-basement membrane glomerulopathy and immune-complex glomerulonephritis: Dichotomy dissolved
117. Possible pathogenic role of cationic anti-DNA autoantibodies in the development of nephritis in patients with systemic lupus erythematosus
118. A novel rat mesangial matrix protein, MMP-50/100, involved in mesangial glomerulopathies
119. Immune complexes bind to cultured rat glomerular mesangial cells to stimulate superoxide release: Evidence for an Fc receptor
120. Passive immune complex glomerulonephritis in mice: Models for various lesions found in human disease. II. Low avidity complexes and diffuse proliferative glomerulonephritis with subepithelial deposits
121. Chronic immune complex disease in mice: The role of antibody affinity
122. Cross-reactions of anti-DNA antibodies and the central dogma of lupus nephritis
123. Endogenous circulating DNA in systemic lupus erythematosus: Occurrence as multimeric complexes bound to histones
124. A monoclonal anti-double-stranded DNA autoantibody binds to a 94-kDa cell-surface protein on various cell types via nucleosomes or a DNA-histone complex
125. Different mechanisms by which anti-DNA Moabs bind to human endothelial cells and glomerular mesangial cells
126. Histories in lupus nephritis
127. Apoptosis, nucleosomes, and nephritis in systemic lupus erythematosus
128. Histones have high affinity for the glomerular basement membrane. Relevance for immune complex formation in lupus nephritis
129. Murine lupus glomerulotropic monoclonal antibodies exhibit differing specificities but bind via a common mechanism
130. DNA mimics a self-protein that may be a target for some anti-DNA antibodies in systemic lupus erythematosus
131. Characterization and in vivo transfer of nephritogenic autoantibodies directed against dipeptidyl peptidase IV and laminin in experimental lupus nephritis
132. Characterization of reactivity of monoclonal antibodies with renal antigens in experimental lupus nephritis
133. Murine monoclonal anti-DNA antibodies bind directly to glomerular antigens and form immune deposits
134. Recent developments in the understanding of antinuclear autoantibodies
135. Broken dogma: Penetration of autoantibodies into living cells
136. A subgroup of murine monoclonal antideoxyribonucleic acid antibodies traverse the cytoplasm and enter the nucleus in a time- and temperature-dependent manner
137. The role of autoantibodies in the pathogenesis of lupus nephritis
138. Altered glomerular permeability induced by F(ab')2 and Fab' antibodies to renal tubular epithelial antigen
139. A nephritogenic rat monoclonal antibody to mouse aminopeptidase A. Induction of massive albuminuria after a single intravenous injection
140. Cyclosporin A induces long-term unresponsiveness in mercuric chloride-incuced autoimmune golmerulonephritis
141. Susceptibility for infection-related glomerulopathy depends on non-MHC genes
142. Prevention of glomerulosclerosis by early cyclosporine treatment of experimental lupus nephritis
143. The role of B cells in lpr/lpr-induced autoimmunity
144. Influence of antigen distribution on the mediation of immunological glomerular injury
145. Complement synthesis in the injured kidney: Does it have a role in immune complex glomerulonephritis?
146. Antigen-antibody complexes enhance the production of complement component C3 by human mesangial cells
147. Regulation of C3 and factor H synthesis of human glomerular mesangial cells by IL- 1 and interferon-gamma
148. Induction of mediator release from human glomerular mesangial cells by terminal complement components C5b-9
149. Activation of glomerular mesangial cells by the terminal membrane attack complex of complement
150. Markers of complement-dependent and complement-independent glomerular visceral epithelial cell injury in vivo: Expression of antiadhesive proteins and cytoskeletal changes
151. Induction of matrix protein synthesis in human glomerular mesangial cells by the terminal complement complex
152. C5b-8 and C5b-9 modulate the collagen release of human glomerular epithelial cells
153. Local extrahepatic expression of complement genes C3, factor B, C2, and C4 is increased in murine lupus nephritis
154. Effects of complement activation on platelet-activating factor and eicosanoid synthesis in rat mesangial cells
155. Role of leukotrienes and lipoxygenases in glomerular injury
156. Visceral glomerular epithelial cells can proliferate in vivo and synthesize platelet-derived growth factor B-chain
157. Cyclosporin (CS) enhances IL-8 and MCP-1 gene expression and peptide formation by human mesangial cells (MC)
158. Receptors for IgG complexes activate synthesis of monocyte chemoattractant peptide 1 and colony-stimulating factor 1
159. Colony stimulating factor-1 in the induction of lupus nephritis
160. Cytokine-induced production of monocyte chemoattractant protein-1 by cultured human mesangial cells
161. Production and cytokine-mediated regulation of monocyte chemoattractant protein-1 by human proximal tubular epithelial cells
162. TNF alpha induces expression of the chemoattractant cytokine RANTES in cultured mouse mesangial cells
163. Inflammation and glomerular injury
164. New insights into circulating cell-endothelium interactions and their significance for glomerular pathophysiology
165. Glomerulonephritis: From new knowledge on the mechanisms of tissue damage to novel therapies
166. Leukocyte adhesion molecules and kidney diseases
167. The endothelium in glomerular inflammation
168. Vascular cell adhesion molecule-1 (VCAM-1) expression in murine lupus nephritis
169. Intercellular adhesion molecule-1 (ICAM-1) expression is upregulated in autoimmune murine lupus nephritis
170. lpr mice
171. lpr mice with lupus nephritis
172. Effective treatment of experimental lupus nephritis by combined administration of anti-CD11a and anti-CD54 antibodies
173. Cell-mediated immunity in glomerular disease
174. Determinants of focal and segmental glomerulosclerosis in the rat after renal ablation: Evidence for involvement of macrophages and lipids
175. Depletion of CD8 positive cells in nephrotoxic serum nephritis of WKY rats
176. Antibodies against intercellular adhesion molecule-1 and lymphocyte function-associated antigen-1 prevent glomerular injury in rat experimental crescentic glomerulonephritis
177. Antibodies to intercellular adhesion molecule 1/lymphocyte function-associated antigen I prevent crescent formation in rat autoimmune glomerulonephritis
178. Intramesangial passage of mononuclear phagocytes in murine lupus glomerulonephritis
179. Glomerular leukocyte infiltration correlates with development of glomerulosclerosis in experimental lupus nephritis
180. Cytokines in renal inflammation
181. Interleukin-1 and the mesangial cell
182. Interleukin-1 in crescentic glomerulonephritis
183. TGF-β regulation of extracellular matrix
184. Transforming growth factor-β in disease: The dark side of tissue repair
185. Transforming growth factor-β and the glomerular extracellular matrix in renal pathology
186. Basic fibroblast growth factor augments podocyte injury and induces glomerulosclerosis in rats with experimental membranous nephropathy
187. Platelet-derived growth factor and mesangial cells
188. Platelet-derived growth factor: A potentially important cytokine in glomerular disease
189. Thromboxane and prostacyclin differentially regulate murine extracellular matrix gene expression
190. Thromboxane stimulation of mesangial cell fibronectin synthesis is signalled by protein kinase C and modulated by cGMP
191. Rat glomerular mesangial cells synthesize basic fibroblast growth factor. Release, upregulated synthesis, and mitogenicity in mesangial proliferative glomerulonephritis
192. Interleukin-6: An autocrine regulator of mesangial cell growth
193. Tumor necrosis factor and IL-1 in New Zealand Black/White mice: Enhanced gene expression and acceleration of renal injury
194. Increased tumor necrosis factor and IL- 1β gene expression in the kidneys of mice with lupus nephritis
195. Dietary omega-3 lipids delay the onset and progression of autoimmune lupus nephritis by inhibiting transforming growth factor beta mRNA and protein expression
196. Induction of plasminogen activator inhibitor type I in murine lupus-like glomerulonephritis
197. Renal platelet-derived growth factor gene expression in NZB/W F1 mice with lupus and ddY mice with IgA nephropathy
198. TGF-β independent development of glomerulosclerosis in murine chronic graft versus host disease (GvHD)?
199. Long-term thromboxane-synthase inhibition prolongs survival in murine lupus nephritis
200. Effect of a specific endothelin A receptor antagonist on murine lupus nephritis
201. G-monomethyl-L-arginine
202. Linomide administration to mice attenuates the induction of nitric oxide synthase elicited by lipopolysaccharide-activated macrophages and prevents nephritis in MRL/Mp-lpr/lpr mice
203. The effects of short-term treatment with the prostaglandin E1 (PGE1) analog misoprostol on inflammatory mediator production in murine lupus nephritis
204. 2 formation in rat mesangial cells
205. Interleukin-1 dysregulation is an intrinsic defect in macrophages from MRL autoimmuneprone mice
206. Increased responsiveness of B cells in the murine MRL/lpr model of lupus nephritis to interleukin-1 beta
207. Experimental insights into the tubulointerstitial disease accompanying primary glomerular lesions
208. Tubulointerstitial damage in glomerular diseases: Its role in the progression of renal damage
209. Pathways to renal fibrosis
210. The pathogenesis of tubulointerstitial disease associated with glomerulonephritis: The glomerular cytokine theory
211. Relationship between renal function and histological changes found in renal biopsy specimens from patients with persistent glomerular nephritis
212. Systemic mononuclear-cell vasculitis in MRL/Mp-lpr/lpr mice
213. Arteritis in a novel congenic strain of mice derived from MRL/lpr lupus mice - Genetic dissociation from glomerulonephritis and limited autoantibody production
214. Mononuclear-cell pulmonary vasculitis in NZB/W mice. I. Histopathologic evaluation of spontaneously occurring pulmonary infiltrates
215. Analysis of vascular lesions in murine SLE
216. Signal transduction from the extracellular matrix
217. Multi-faceted regulation of cell differentiation by extracellular matrix
218. Transient and locally restricted expression of laminin A chain mRNA by developing epithelial cells during kidney organogenesis
219. Loss of laminin epitopes during glomerular basement membrane assembly in developing mouse kidneys
220. Basement membrane proteoglycans in glomerular morphogenesis: Chondroitin sulfate proteoglycan is temporally and spatially restricted during development
221. Collagen IV α3, α4, and α5 chains in rodent basal laminae: Sequence, distribution, association with laminins, and developmental switches
222. Chronic renal disease: Do metalloproteinase inhibitors have a demonstrable role in extracellular matrix accumulation?
223. Matrix and adhesion molecules in kidney pathology: Recent observations
224. A reappraisal of immune-mediated glomerulosclerosis
225. Decrease of heparan sulfate staining in the glomerular basement membrane in murine lupus nephritis
226. A molecular biologic study of extracellular matrix components during the development of glomerulosclerosis in murine chronic graft-versus-host disease
227. Qualitative alterations in laminin expression in experimental lupus nephritis
228. Cloning of the mouse fibronectin V-region and variation of its splicing pattern in experimental immune complex glomerulonephritis
229. Differential expression of laminin chains and anti-laminin autoantibodies in experimental lupus nephritis
230. Structure and function of laminin: Anatomy of a multidomain glycoprotein
231. Laminins and other strange proteins
232. Redistribution of glomerular dipeptidyl peptidase type IV in experimental lupus nephritis. Demonstration of decreased enzyme activity at the ultrastructural level
233. Gender-related influences on the development of chronic graft-versus-host disease-induced experimental lupus nephritis
234. The B cell repertoire in mercuric chloride-induced systemic autoimmunity in DZB rats
235. Dexamethasone prevents autoimmune nephritis and reduces renal expression of Ia but not costimulatory signals
236. + T cells
237. Renal tubular epithelial and T cell interactions in autoimmune renal disease
238. The antigen presentation function of renal tubular epithelial cells
239. Mesangial cell accessory functions: Mediation by intracellular adhesion molecule-1
240. Antigen processing and presentation by glomerular visceral epithelium in vitro
241. Antigen-specific therapy of murine lupus nephritis using nucleosomal peptides: Tolerance spreading impairs pathogenic function of autoimmune T and B cells
242. Lymphocyte abnormalities in human lupus
243. B-cell abnormalities characteristic of systemic lupus erythematosus
244. Autoepitopes in lupus
245. Antibodies to CD45 and other cell membrane antigens in systemic lupus erythematosus
246. Human anti-fibronectin antibodies in systemic lupus erythematosus: Occurrence and antigenic specificity
247. Autoantibodies to vascular heparan sulfate proteoglycan in systemic lupus erythematosus react with endothelial cells and inhibit the formation of thrombin-antithrombin III complexes
248. Comparison of the anti-laminin antibody response in patients with systemic lupus erythematosus (SLE) and parasitic diseases (filariasis)
249. Association of glomerular and interstitial mononuclear leukocytes with different forms of glomerulonephritis
250. Distinct patterns of expression of ICAM-1, VCAM-1, and ELAM-1 in renal disease
251. Up-regulated MHC-class II expression and gamma-IFN and soluble IL-2R in lupus nephritis
252. Expression of transforming growth factor-beta isoforms in human glomerular disease
253. Expression of types I, II, III TGF-beta receptors in human glomerulonephritis
254. Expression of connective tissue growth factor in human renal fibrosis
255. Involvement of IL-4 in human glomerulonephritis: An in situ hybridization study of IL-4 mRNA and IL-4 receptor mRNA
256. Expression of endothelial and inducible nitric oxide synthase in human glomerulonephritis
257. The composition of glomerulosclerosis I. Studies in focal sclerosis, crescentic glomerulonephritis, and membranoproliferative glomerulonephritis
258. Expression of betal-integrins on activated mesangial cells in human glomerulonephritis
259. Distribution of GBM heparan sulfate proteoglycan core protein and side chains in human glomerular diseases
260. Modern renal biopsy interpretation: Can we predict glomerulosclerosis?
261. Immunosuppressive drug therapy in lupus nephritis
262. Effect of a specific endothelin A receptor antagonist on murine lupus nephritis
263. Gene transfer into the rat renal glomerulus via a mesangial cell vector: Site-specific delivery, in situ amplification, and sustained expression of an exogenous gene in vivo